This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Shell Ip
Advertisement
Shell Ip, PhD, is a technical marketing specialist at Precision Nanosystems.
Articles by Shell Ip
Advertisement
Latest Updated Articles
Accelerating Genetic Medicine R&D Using MicrofluidicsPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
